Pituitary Diseases - 25 Studies Found
Withdrawn |
: Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas : Resectable, Non-functioning Pituitary Adenoma : 2010-07-28 : Drug: Farletuzumab Farletuzumab initial loading dose 5.0 mg/kg intravenous followed by 2.5 mg/kg intrave |
Completed |
: Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors :
: 2015-01-14 :
|
Recruiting |
: Post-Operative Water Load Following Transsphenoidal Pituitary Surgery :
: 2016-03-23 : Other: Water Load (WL) Post-Operative Day 1 Patient will have normonatremic 0600 hr sodium level (Serum |
Completed |
: Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities :
|
Recruiting |
: Predictive Factors of Recurrence of Non Functioning Pituitary Adenomas : a Retrospective Study of 220 Patients in the Reims University Hospital, France : Pituitary Adenomas : 2016-06-09 : Other: Patients |